Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 5;109(23):9209-12.
doi: 10.1073/pnas.1201416109. Epub 2012 May 21.

Molecular signaling network complexity is correlated with cancer patient survivability

Affiliations

Molecular signaling network complexity is correlated with cancer patient survivability

Dylan Breitkreutz et al. Proc Natl Acad Sci U S A. .

Abstract

The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on tumor type. Prostate cancer patients have a >99% chance of survival past 5 y after diagnosis, and pancreatic patients have <6% chance of survival past 5 y. Because each cancer type has its own molecular signaling network, we asked if there are "signatures" embedded in these networks that inform us as to the 5-y survival. In other words, are there statistical metrics of the network that correlate with survival? Furthermore, if there are, can such signatures provide clues to selecting new therapeutic targets? From the Kyoto Encyclopedia of Genes and Genomes Cancer Pathway database we computed several conventional and some less conventional network statistics. In particular we found a correlation (R(2) = 0.7) between degree-entropy and 5-y survival based on the Surveillance Epidemiology and End Results database. This correlation suggests that cancers that have a more complex molecular pathway are more refractory than those with less complex molecular pathway. We also found potential new molecular targets for drugs by computing the betweenness--a statistical metric of the centrality of a node--for the molecular networks.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Protein–protein interaction network for basal cell carcinoma as constructed from the KEGG pathway processed by KEGGgraph. Node labels are HGNC gene symbols. Yellow nodes are the top three highest in betweenness centrality.
Fig. 2.
Fig. 2.
Scatter plot showing the correlation between cancer 5-y survival probability and degree-entropy. Datapoints are shown for 13 cancer sites, including all of the cancer sites with KEGG pathways, except prostate cancer. The x axis is the 5-y survival probability for the cancer site, from the SEER database. The y axis is the degree-entropy (H) for the cancer site, calculated from the KEGG pathway. The line is a linear regression fit, with R2 = 0.7. The error bars are set at fixed estimates of the error, with the x axis error bars fixed at ±10% and the y axis error bars fixed at ±0.1.

References

    1. MacDonald P. Chemotherapeutic Drugs. In: Scheinemann K, Boyce AE, editors. Emergencies in Pediatric Oncology. New York: Springer; 2012. pp. 105–120.
    1. Kandalaft LE, Motz GT, Busch J, Coukos G. Angiogenesis and the tumor vasculature as antitumor immune modulators: The role of vascular endothelial growth factor and endothelin. Curr Top Microbiol Immunol. 2011;344:129–148. - PubMed
    1. Marshall E. Cancer research and the $90 billion metaphor. Science. 2011;331:1540–1541. - PubMed
    1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet. 2002;360:1131–1135. - PubMed
    1. Ellison LF, Gibbons L. Survival from cancer—Up-to-date predictions using period analysis. Health Rep. 2006;17:19–30. - PubMed

Publication types

LinkOut - more resources